Jennifer Robertson

发表

Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis

C. Charrier, D. Mercer, D. O'Neil, 2014, Orphanet Journal of Rare Diseases.

Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum

D. Mercer, G. Devereux, D. O'Neil, 2015, EBioMedicine.

VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis

G. Garber, Chatura Prematunge, J. Johnstone, 2015, Infection Control & Hospital Epidemiology.

Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity

D. Mercer, C. Munro, Vanessa M S Duncan, 2021, Antimicrobial agents and chemotherapy.

Novel fluorinated lipopeptides from Bacillus sp. CS93 via precursor-directed biosynthesis

C. Murphy, S. Cobb, Vanessa M S Duncan, 2014, Amino Acids.

Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate

D. Mercer, C. Stewart, D. O'Neil, 2019, Antimicrobial Agents and Chemotherapy.

A Prodrug Approach to the Use of Coumarins as Potential Therapeutics for Superficial Mycoses

D. Mercer, C. Stewart, D. O'Neil, 2013, PloS one.

NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile

D. Mercer, C. Stewart, D. O'Neil, 2020, Medical mycology.

NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus

D. Mercer, Fiona Hewitt, D. O'Neil, 2017, Antimicrobial Agents and Chemotherapy.

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial

V. Lucidi, G. Devereux, C. Daines, 2020, PloS one.

Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex

D. Mercer, D. O'Neil, D. Fraser-Pitt, 2016, Antimicrobial Agents and Chemotherapy.

Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection

N. Woodford, K. Hopkins, D. Mercer, 2018, Infection and Immunity.

Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection

N. Woodford, K. Hopkins, D. Mercer, 2018 .

Novel fluorinated lipopeptides from Bacillus sp. CS93 via precursor-directed biosynthesis

C. Murphy, S. Cobb, D. O'Neil, 2014, Amino Acids.

893Vancomycin Resistant Enterococcus (VRE) Rates in Ontario, Canada After the Discontinuation of VRE Screening and Control Practices by Some Hospitals: Interim Results

G. Garber, Chatura Prematunge, J. Johnstone, 2014, Open Forum Infectious Diseases.